EXHIBIT 99.1

 

 

 

FOR IMMEDIATE RELEASE: July 13, 2021

 

 

Aspen Group Reports Record Revenue of $67.8 million or 38% Growth in Fiscal Year 2021

 

·BSN Pre-Licensure and USU fourth quarter 2021 revenue accounted for 51% of consolidated revenue
·Introduces Full-year Guidance for Fiscal 2022

 

NEW YORK, NY –July 13, 2021 - Aspen Group, Inc. (Nasdaq: ASPU) ("AGI"), an education technology holding company, today announced financial results for its fourth quarter and fiscal year ended April 30, 2021, and introduced guidance for revenue, Net income (loss), GAAP earnings per share, EBITDA and Adjusted EBITDA for fiscal year 2022.

 

Fourth Quarter and Full Year 2021 Summary Results Table

   Three Months Ended Twelve Months Ended
$ in millions, except per share data (rounding differences may occur) April 30, 2021 April 30, 2020 April 30, 2021 April 30, 2020
Revenue $19.1 $14.1 $67.8 $49.1
GAAP Gross Profit1 $9.9 $8.4 $36.9 $28.9
GAAP Gross Margin (%)1 52% 59% 54% 59%
Operating Income (Loss) ($2.3) ($0.3) ($8.2) ($4.0)
Net Income (Loss) ($2.3) ($0.7) ($10.4) ($5.7)
Earnings (Loss) per Share ($0.09) ($0.03) ($0.44) ($0.29)
EBITDA Profit/(Loss) 2 ($1.4) $0.2 ($6.0) ($1.6)
Adjusted EBITDA Profit/(Loss) 2 $0.6 $1.4 $1.3 $2.7

1 GAAP gross profit calculation includes marketing and promotional costs, instructional costs & services, and amortization expense.

2 Non-GAAP financial measure. See reconciliations of GAAP to non-GAAP financial measures under "Non-GAAPFinancial Measures" starting on page 5.

 

"Aspen Group finished the fiscal year with solid momentum in our three business units, which produced 35% year-over-year revenue growth in the fourth quarter and 38% for the full year. Each of our business units delivered impressive growth, with USU's MSN-FNP and Aspen University's BSN Pre-Licensure programs being the most significant contributors," said Michael Mathews, Chairman and CEO of AGI. “We are introducing full year guidance and a plan to manage expenses while continuing to deliver industry-leading growth rates. This gives us a clear line of sight to reducing losses and cash burn, with the goal of achieving profitability in Q4 of fiscal year 2022.”

 

 
 

 

Fiscal Q4 2021 Financial and Operational Results (versus Fiscal Q4 2020)

 

Revenues increased 35% to $19.1 million for Fiscal Q4 2021, compared to $14.1 million in Fiscal Q4 2020. USU accounted for 30%, and AU's BSN Pre-Licensure program accounted for 21% of the Company’s consolidated revenues.

 

Gross profit increased by 19% to $9.9 million or 52% gross margin for Fiscal Q4 2021 versus $8.4 million or 59% gross margin in Fiscal Q4 2020. The year-over-year gross margin decrease was an expected result following the launch of three new BSN Pre-Licensure campuses and gross margin is expected to improve throughout Fiscal Year 2022. AU gross margin represented 52% of AU revenues for Fiscal Q4 2021, and USU gross margin represented 57% of USU revenues for Fiscal Q4 2021.

 

AU instructional costs and services represented 24% of AU revenues for Fiscal Q4 2021, while USU instructional costs and services represented 25% of USU revenues for Fiscal Q4 2021. AU marketing and promotional costs represented 21% of AU revenues for Fiscal Q4 2021, while USU marketing and promotional costs represented 18% of USU revenues for Fiscal Q4 2021.

 

Net loss was ($2.3 million) or net loss per basic share of ($0.09) for Fiscal Q4 2021 versus ($0.7 million) or ($0.03) for the prior-year period. For Fiscal Q4 2021, AU generated $1.4 million of net income, and USU generated $1.0 million of net income. AGI corporate incurred a net loss of ($4.7 million) for Fiscal Q4 2021.

 

EBITDA, a non-GAAP financial measure, was ($1.4 million) or (8%) margin in Fiscal Q4 2021, as compared to EBITDA of $0.2 million or 2% margin in Fiscal Q4 2020. Adjusted EBITDA, a non-GAAP financial measure, was $0.6 million or 3% margin in Fiscal Q4 2021, as compared to $1.4 million or 10% margin in the prior-year period.

 

AU generated EBITDA of $2.2 million or 16% margin and Adjusted EBITDA of $2.6 million or 20% margin for Fiscal Q4 2021. In Fiscal Q4 2021, AU’s BSN Pre-Licensure program accounted for $0.9 million of the $2.2 million EBITDA generated at AU, operating at an EBITDA margin of 24%, which is the highest EBITDA margin unit of the Company. USU generated EBITDA of $1.1 million or 19% margin and $1.4 million of Adjusted EBITDA or 24% margin in the Fiscal Q4 2021. AGI corporate incurred EBITDA of ($4.7 million) and Adjusted EBITDA of ($3.3 million) for Fiscal Q4 2021, which includes $1.1 million of one-time expense items.

 

Fiscal Year 2021 Full Year Financial and Operational Results (versus Fiscal Year 2020)

 

Revenues increased 38% to $67.8 million for Fiscal Year 2021, compared to $49.1 million in the prior year. For Fiscal Year 2021, USU accounted for 29%, and AU's BSN Pre-Licensure program accounted for 21% of the Company’s consolidated revenues.

 

Gross profit increased by 28% to $36.9 million or 54% gross margin for Fiscal Year 2021 versus $28.9 million or 59% gross margin in the prior year. For Fiscal Year 2021, AU gross margin represented 55% of AU revenues, and USU gross margin represented 58% of USU revenues.

 

For Fiscal Year 2021, AU instructional costs and services represented 22% of AU revenues, while USU instructional costs and services represented 25% of USU revenues. AU marketing and promotional costs represented 20% of AU revenues for Fiscal Year 2021, while USU marketing and promotional costs represented 18% of USU revenues.

Net loss was ($10.4 million) or net loss per basic share of ($0.44) for Fiscal Year 2021 versus ($5.7 million) or ($0.29) in the prior year period. AU generated $7.3 million of net income, and USU generated $2.9 million of net income in Fiscal Year 2021. AGI corporate incurred a net loss of ($20.7 million) for Fiscal Year 2021.

 

EBITDA, a non-GAAP financial measure, was ($6.0 million) or (9%) margin in Fiscal Year 2021 as compared to EBITDA of ($1.6 million) or (3%) margin in the prior year period. Adjusted EBITDA, a non-GAAP financial measure, was $1.3 million or 2% margin in Fiscal Year 2021 compared to Adjusted EBITDA of $2.7 million or 6% margin in the prior year.

 

 
 

 

 

AU generated EBITDA of $9.5 million or 20% margin and Adjusted EBITDA of $11.6 million or 24% margin for Fiscal Year 2021. AU’s BSN Pre-Licensure program accounted for $4.1 million of the $9.5 million EBITDA generated at AU, operating at an EBITDA margin of 29%, the highest margin unit of the Company. USU generated EBITDA of $3.1 million or 16% margin and $3.6 million of Adjusted EBITDA or 18% margin in the Fiscal Year 2021. AGI corporate incurred EBITDA of ($18.6 million), and Adjusted EBITDA of ($14.0 million), which reflects $2.7 million of one-time expense items.

 

Liquidity

 

At April 30, 2021, the Company reported unrestricted cash and cash equivalents of $8.5 million and total liquidity of $13.5 million, including our undrawn $5 million credit facility, which was a decrease of unrestricted cash and cash equivalents of $5.8 million for the full fiscal year 2021 or a sequential decrease from Fiscal Q3 2021 of $1.5 million.

 

Outlook for Fiscal Year 2022

 

Mr. Mathews continued, "We see several growth drivers for fiscal 2022. We expect that the move to double cohorts for our high-LTV BSN Pre-Licensure program at our main Phoenix campus will increase revenue from the Phoenix metro to approximately $18 million, which offsets the lower planned enrollments in the Phoenix metro due to the pipeline of first-year (pre-professional nursing) PPN online students nearing its target capacity. Another growth driver will be USU's MSN-FNP program, our second highest LTV program, where the tremendous growth we have seen to date is expected to continue. The third growth driver will be continued enrollment growth and class starts at our new BSN Pre-licensure campuses in Austin, Tampa, and Nashville.”

 

"The Company is introducing today a business plan that we are calling ‘Aspen 2.0.’ Aspen 2.0 is designed to deliver maximum efficiency as defined by revenue earned from each marketing dollar spent. Growth spending will be focused on our highest efficiency businesses to accelerate the growth in these units, with decreased spending in our lowest efficiency unit (an area where high growth is not essential), specifically, we plan to reduce marketing spending in our traditional AU Nursing + Unit. In addition, we plan to reduce spending in our Phoenix metro BSN Pre-Licensure, which is nearing capacity. Those marketing dollars will be redirected towards high LTV programs, specifically our three new BSN Pre-Licensure metros, AU’s online doctoral programs, and USU's MSN-FNP program.

 

We’re forecasting that this ‘maximum efficiency’ spending plan will result in roughly a 1% total enrollment increase, translating to an increase of bookings year-over-year of 6%, from $143.4 million to $151.3 million, which continues to set the Company up for consistent, sustained growth in the coming years. Moreover, this spending plan is forecasted to decrease our advertising spending to approximately 17% of revenue in fiscal 2022, down from 19% in fiscal 2021.

 

Lastly, we plan to delay our next BSN Pre-Licensure campus launch to the Spring of 2022, or approximately at the end of fiscal year 2022. Our next metro launch will be in a Tier 1 market with a population larger than the Phoenix metro. The combination of reducing advertising spend growth and pushing out the next BSN Pre-Licensure campus launch gives us a clear line of sight to increasing leverage, lowering cash burn and reducing losses in fiscal 2022. We believe this will permit us to achieve our near-term goal of GAAP profitability and turning cash flow positive by the fourth quarter of fiscal 2022.”

 

The table below shows the Company’s guidance for fiscal year 2022:

 

(Dollar amounts in millions except EPS) Guidance Range Growth Rate (%)1

YoY Increase1

Revenue $85.0 $88.0 27.0% +$18.7
Net Income (Loss)2 ($4.5) ($3.0) 64% +$6.7
GAAP Earnings (Loss) per Share2 ($0.18) ($0.12) 66% +$0.29
EBITDA3 ($1.6) $0.4 90% +$5.4
Adjusted EBITDA3 $2.0 $4.0 137% +$1.7

1 Year-over-year growth rate or increase is calculated from the mid-point of the guidance range.

2 The Company anticipates positive GAAP net income and earnings per share in the fourth quarter of fiscal year 2022.

 

 
 


 

3 Non-GAAP financial measure. See reconciliations of GAAP to Non-GAAP financial measures under "Non-GAAP–Financial Measures" starting on page 5.

 

The table below shows the actual advertising spend, enrollments and bookings by university for fiscal year 2021 and estimated advertising spend, enrollments and bookings by university for fiscal year 2022, as well as forecasted year-over-year changes.

 

Advertising Budgets, Enrollments and Bookings by University

 

 

Fiscal Year 2021

(actual)

Fiscal Year 2022

(forecast)

(Dollar amounts in millions) Advertising Spend Enrollments Bookings Advertising Spend Enrollments Bookings
AU Total $9.3 6,975 $101.6 $10.0 6,470* $98.7
Forecasted Change (%)       8% (-7%) (-3%)
USU (primarily MSN-FNP) $3.5 2,346 $41.8 $4.4 2,950 $52.6
Forecasted Change (%)       26% 26% 26%
Universities Total $12.8 9,321 $143.4 $14.4 9,420 $151.3
As a % of Total Revenue 19%     17%    
Forecasted Change (%)       13% 1% 6%

*AU has begun proactively reducing spend and enrollments in the BSN Pre-Licensure Phoenix market given the pipeline of first-year Pre-Professional Nursing (PPN) online students in the Phoenix metro is nearing its 1,650 target capacity. Consequently, AU projects ~1,000 BSN Pre-Licensure enrollments in the Phoenix metro in FY’22, a reduction from ~1,600 in FY’21.

 

Fiscal Q4 2021 Earnings Conference Call Details:

 

Aspen Group will host a conference call to discuss its fourth quarter and full-year fiscal 2021 financial results and business outlook on Tuesday, July 13, 2021, at 4:30 p.m. (ET). 

 

The conference call can be accessed by dialing toll-free (844) 452-6823 (US) or (731) 256-5216 (international), passcode 4168399. After the call, a transcript of the audio cast will be available on the Company's website at ir.aspen.edu. There will also be a seven-day dial-in replay which can be accessed by dialing toll-free (855) 859-2056 (US) or (404) 537-3406 (international), passcode 4168399.

 

Non-GAAP – Financial Measures:

 

This press release includes both financial measures in accordance with the Generally Accepted Accounting Principles, or GAAP, as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternatives to net income (loss), operating income (loss), and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of AGI nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP.

 

 
 

 

 

Our management uses and relies on Adjusted EBITDA and EBITDA, each of which are non-GAAP financial measures. We believe that both management and shareholders benefit from referring to these non-GAAP financial measures in planning, forecasting and analyzing future periods. Our management uses these non-GAAP financial measures in evaluating its financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the excluded items described below.

 

AGI defines Adjusted EBITDA as earnings (or loss) from operations before the items in the table below. It is important to note that there were $1,134,629 of non-recurring charges for the fiscal quarter ended April 30, 2021 compared to $77,000 in the fiscal quarter ended April 30, 2020. Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and analysts to evaluate and assess our core operating results from period-to-period after removing the impact of items of a non-recurring nature that affect comparability.

 

We have included a reconciliation of our non-GAAP financial measures to the most comparable financial measures calculated in accordance with GAAP. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between AGI and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measure and the corresponding GAAP measure provided by each Company under applicable SEC rules.

 

AGI defines Adjusted EBITDA as EBITDA excluding: (1) bad debt expense; (2) stock-based compensation; and (3) other non-recurring charges. The following table presents a reconciliation of net loss to EBITDA and Adjusted EBITDA:

  Three Months Ended
April 30,
  For the Year Ended
April 30,
  2021   2020   2021   2020
Net loss $ (2,319,986)     $ (664,563)     $ (10,448,973)     $ (5,659,065)  
Interest expense, net 13,369      393,471      2,031,545      1,818,078   
Taxes (12,446)     (10,688)     32,644      51,820   
Depreciation and amortization 874,111      493,268      2,426,365      2,203,461   
EBITDA (1,444,952)     211,488      (5,958,419)     (1,585,706)  
Bad debt expense 566,540      780,005      2,268,540      1,431,210   
Stock-based compensation 382,936      300,740      2,203,822      1,641,984   
Non-recurring charges - Other stock-based compensation 555,321      —      1,754,263      474,324   
Non-recurring charges - Severance 303,870      —      347,870      218,750   
Non-recurring charges - Other 275,438      77,000      650,875      526,998   
Adjusted EBITDA $ 639,153      $ 1,369,233      $ 1,266,951      $ 2,707,560   

 

 
 

 

 

The following tables present a reconciliation of net income (loss) to EBITDA and Adjusted EBITDA by business unit:

 

  Three Months Ended April 30, 2021
  Consolidated   AGI Corporate   Aspen BSN Pre-Licensure   AU Online   AU Total   USU
Net income (loss) $ (2,319,986)     $ (4,736,579)     $ 831,192      $ 557,608      $ 1,388,800      $ 1,027,793   
Interest expense, net 13,369      13,486      —      —      —      (117)  
Taxes (12,446)     (14,250)     —      2,064      2,064      (260)  
Depreciation and amortization 874,111      15,691      114,618      671,517      786,135      72,285   
EBITDA (1,444,952)     (4,721,652)     945,810      1,231,189      2,176,999      1,099,701   
Bad debt expense 566,540      —      —      340,000      340,000      226,540   
Stock-based compensation 382,936      275,938      —      75,605      75,605      31,393   
Non-recurring charges – Other stock-based compensation 555,321      555,321      —      —      —      —   
Non-recurring charges - Severance 303,870      303,870      —      —      —      —   
Non-recurring charges - Other 275,438      239,438            —      36,000      36,000      —   
Adjusted EBITDA $ 639,153      $ (3,347,085)     $ 945,810      $ 1,682,794      $ 2,628,604      $ 1,357,634   

 

  Year Ended April 30, 2021
  Consolidated   AGI Corporate   Aspen BSN Pre-Licensure   AU Online   AU Total   USU
Net income (loss) $ (10,448,973)     $ (20,666,448)     $ 3,895,576      $ 3,386,117      $ 7,281,693      $ 2,935,782   
Interest expense, net 2,031,545      2,031,745      —      —      —      (200)  
Taxes 32,644      —      —      32,644      32,644      —   
Depreciation and amortization 2,426,365      57,713      189,618      2,020,548      2,210,166      158,486   
EBITDA (5,958,419)     (18,576,990)     4,085,194      5,439,309      9,524,503      3,094,068   
Bad debt expense 2,268,540      —      —      1,862,000      1,862,000      406,540   
Stock-based compensation 2,203,822      1,845,683      —      210,771      210,771      147,368   
Non-recurring charges – Other stock-based compensation 1,754,263      1,754,263      —      —      —      —   
Non-recurring charges - Severance 347,870      347,870      —      —      —      —   
Non-recurring charges - Other 650,875      614,875      —      36,000      36,000      —   
Adjusted EBITDA $ 1,266,951      $ (14,014,299)     $ 4,085,194      $ 7,548,080      $ 11,633,274      $ 3,647,976   

 

 
 

 

 

Guidance for Fiscal Year 2022

The following table presents a reconciliation of net loss to EBITDA and Adjusted EBITDA for fiscal year 2022 Guidance ranges (dollar amounts in millions):

  Fiscal Year 2022 Guidance Range
Net loss ($4.5) - ($3.0)
Interest expense, net 0.1   
Taxes —   
Depreciation and amortization 2.8 - 3.3
EBITDA ($1.6) - $0.4
Bad debt expense 1.0   
Stock-based compensation 2.7   
Non-recurring charges (0.1)  
Adjusted EBITDA $2.0 - $4.0

 

Definitions

 

Bookings - defined by multiplying Lifetime Value by new student enrollments for each operating unit.

 

LTV or Lifetime Value - Lifetime Value is the weighted average total amount of tuition and fees paid by every new student that enrolls in the Company's universities, after giving effect to attrition.

 

EBITDA Margin - is defined as EBITDA divided by revenues. We believe EBITDA margin is useful for analysts and investors as this measure allows a more meaningful comparison between our performance and that of our competitors. EBITDA margin has certain limitations in that it does not take into account the impact to our consolidated statement of operations of certain expenses.

 

Adjusted EBITDA Margin - is defined as Adjusted EBITDA divided by revenues. We believe Adjusted EBITDA margin is useful for analysts and investors as this measure allows a more meaningful comparison between our performance and that of our competitors. Adjusted EBITDA margin has certain limitations in that it does not take into account the impact to our consolidated statement of operations of certain expenses.

 

 
 

 

 

Forward-Looking Statements:

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including the Company’s expected future operating results including its goal of achieving profitability in the fourth quarter of Fiscal 2022, the expected growth in Fiscal 2022 and the drivers for such growth, the expected increase in revenue from the Phoenix metro and its anticipated impact on our results, our plans to reduce advertising spending year-over-year in the AU Nursing + Unit and in our BSN Pre-Licensure Phoenix metro, and redirect that advertising spend towards our highest LTV programs, our expectations with respect to future increased leverage, lower cash burn, and reduced losses, anticipated changes in enrollments and bookings in fiscal 2022, the anticipated continued growth in the USU's MSN-FNP program and the expected timing of the next BSN Pre-Licensure campus launch. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include the continued demand of nursing students for the new programs, student attrition, any further spread of COVID-19, national and local economic factors including the future impact of the COVID-19 pandemic on the economy, the competitive impact from the trend of major non-profit universities using online education, the receipt of necessary regulatory approvals for the new campus, and the risk that the Company’s assumptions with respect to its fiscal year 2022 performance may be incorrect. Other risks are included in our filings with the SEC including our Form 10-K for the year ended April 30, 2021. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

 

About Aspen Group, Inc.:

 

Aspen Group, Inc. is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again.

 

Investor Relations Contact:

 

Kim Rogers
Managing Director
Hayden IR
385-831-7337 
Kim@HaydenIR.com

 

 

 

 
 

 

GAAP Financial Statements

 

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

  April 30,
  2021   2020
Assets      
       
Current assets:      
Cash and cash equivalents $ 8,513,290      $ 14,350,554   
Restricted cash 5,152,789      3,556,211   
Accounts receivable, net of allowance of $3,289,816 and $1,758,920, respectively 16,724,744      14,326,791   
Prepaid expenses 1,077,831      941,671   
Other receivables —      23,097   
Other current assets 68,529      173,090   
Total current assets 31,537,183      33,371,414   
       
Property and equipment:      
   Computer equipment and hardware 956,463      649,927   
   Furniture and fixtures 1,705,101      1,007,099   
   Leasehold improvements 5,729,324      867,024   
   Instructional equipment 421,039      301,842   
   Software 8,488,635      6,162,770   
   Construction in progress 247,767      —   
  17,548,329      8,988,662   
   Less: accumulated depreciation and amortization (4,892,987)     (2,841,019)  
      Total property and equipment, net 12,655,342      6,147,643   
Goodwill 5,011,432      5,011,432   
Intangible assets, net 7,908,360      7,900,000   
Courseware, net 187,296      111,457   
Accounts receivable, net of allowance of $625,963, and $625,963, respectively 45,329      45,329   
Long term contractual accounts receivable 10,249,833      6,701,136   
Debt issue cost, net 18,056      182,418   
Operating lease right of use assets, net 12,714,863      6,412,851   
Deposits and other assets 479,212      355,831   
Total assets $ 80,806,906      $ 66,239,511   

(Continued)

 

 
 

 

 

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (CONTINUED)

  April 30,
  2021   2020
Liabilities and Stockholders’ Equity      
Current liabilities:      
Accounts payable $ 1,466,488      $ 1,505,859   
Accrued expenses 2,040,896      900,643   
Deferred revenue 6,825,014      3,712,994   
Due to students 2,747,484      2,371,844   
Operating lease obligations, current portion 2,029,821      1,683,252   
Other current liabilities 307,921      182,481   
Total current liabilities 15,417,624      10,357,073   
       
Convertible notes, net of discount of $0 and $1,550,854, respectively —      8,449,146   
Operating lease obligations, less current portion 16,298,808      5,685,335   
Total liabilities 31,716,432      24,491,554   
       
Commitments and contingencies      
       
Stockholders’ equity:      
Preferred stock, $0.001 par value; 1,000,000 shares authorized,      
   0 issued and 0 outstanding at April 30, 2021 and April 30, 2020 —      —   
Common stock, $0.001 par value; 40,000,000 shares authorized,      
   25,066,297 issued and 24,910,811 outstanding at April 30, 2021      
   21,770,520 issued and 21,753,853 outstanding at April 30, 2020 25,067      21,771   
Additional paid-in capital 109,040,824      89,505,216   
Treasury stock (155,486 and 16,667 shares, respectively) (1,817,414)     (70,000)  
Accumulated deficit (58,158,003)     (47,709,030)  
Total stockholders’ equity 49,090,474      41,747,957   
Total liabilities and stockholders’ equity $ 80,806,906      $ 66,239,511   

 

 
 

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

 

  Years Ended April 30,
  2021   2020
Revenues $ 67,812,520      $ 49,061,080   
       
Operating expenses      
Cost of revenues (exclusive of depreciation and amortization shown separately below) 29,453,733      19,135,302   
General and administrative 41,908,030      30,329,520   
Bad debt expense 2,268,540      1,431,210   
Depreciation and amortization 2,426,365      2,203,461   
Total operating expenses 76,056,668      53,099,493   
       
Operating loss (8,244,148)     (4,038,413)  
       
Other income (expense):      
Other (expense) income (120,800)     249,246   
Interest expense (2,051,381)     (1,818,078)  
Total other expense, net (2,172,181)     (1,568,832)  
       
Loss before income taxes (10,416,329)     (5,607,245)  
       
Income tax expense 32,644      51,820   
       
Net loss $ (10,448,973)     $ (5,659,065)  
       
Net loss per share - basic and diluted $ (0.44)     $ (0.29)  
       
Weighted average number of common shares outstanding - basic and diluted 23,757,656      19,708,708   

 

 

 
 

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

YEARS ENDED APRIL 30, 2021 AND 2020

 

  Common Stock   Additional
Paid-In
Capital
 

Treasury

Stock

 

Accumulated

Deficit

  Total
Stockholders'
Equity
  Shares   Amount        
Balance as of April 30, 2019 18,665,551      $ 18,666      $ 68,562,727      $ (70,000)     $ (42,049,965)     $ 26,461,428   
Stock-based compensation —      —      2,116,309      —      —      2,116,309   
Amortization of restricted stock issued for services —      —      122,250      —      —      122,250   
Common stock issued for cashless exercise of stock options 190,559      191      (191)     —      —      —   
Common stock issued for stock options exercised for cash 277,678      278      962,372      —      —      962,650   
Common stock issued for cashless warrant exercise 76,929      77      (77)     —      —      —   
Amortization of warrant based cost issued for services —      —      36,719      —      —      36,719   
Restricted stock issued for services, subject to vesting 144,803      144      (144)     —      —      —   
Common stock issued for equity raise, net of underwriter costs of $1,222,371 2,415,000      2,415      16,042,464      —      —      16,044,879   
Other offering costs —      —      (51,282)     —      —      (51,282)  
Beneficial conversion feature on Convertible Debt —      —      1,692,309      —      —      1,692,309   
Common stock short swing reclamation —      —      21,760      —      —      21,760   
Net loss —      —      —      —      (5,659,065)     (5,659,065)  
Balance as of April 30, 2020 21,770,520      $ 21,771      $ 89,505,216      $ (70,000)     $ (47,709,030)     $ 41,747,957   
Stock-based compensation —      —      3,958,085      —      —      3,958,085   
Common stock issued for stock options exercised for cash 1,389,463      1,389      4,485,272      (1,817,414)     —      2,669,247   
Common stock issued for cashless exercise of stock options 34,773      35      (35)     —      —      —   
Common stock issued for conversion of Convertible Notes 1,398,602      1,399      9,998,601      —      —      10,000,000   
Common stock issued for vested restricted stock units 295,557      296      (296)     —      —      —   
Common stock issued for warrants exercised for cash 192,049      192      1,081,600      —      —      1,081,792   
Common stock issued for services 2,000          19,898      —      —      19,900   
Modification charge for warrants exercised —      —      25,966      —      —      25,966   
Amortization of warrant based cost issued for services —      —      36,500      —      —      36,500   
Cancellation of treasury stock (16,667)     (17)     (69,983)     70,000      —      —   
Net loss —      —      —      —      (10,448,973)     (10,448,973)  
Balance as of April 30, 2021 25,066,297      $ 25,067      $ 109,040,824      $ (1,817,414)     $ (58,158,003)     $ 49,090,474   

 

 

 
 

 

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

  Years Ended April 30,
  2021   2020
Cash flows from operating activities:      
Net loss $ (10,448,973)     $ (5,659,065)  
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Bad debt expense 2,268,540      1,431,210   
Depreciation and amortization 2,426,365      2,203,461   
Stock-based compensation 3,958,085      2,116,309   
Amortization of warrant based cost 36,500      36,719   
Amortization of debt discounts 1,550,854      261,128   
Amortization of debt issue costs 164,362      118,406   
Modification charge for warrants exercised 25,966      —   
Common stock issued for services 19,900      122,250   
Loss on asset disposition —      3,918   
Gain on extinguishment of debt —      (50,000)  
Lease (benefit) expense (27,796)     162,127   
Tenant improvement allowances received from landlords 4,685,826      —   
Changes in operating assets and liabilities:      
Accounts receivable (8,215,190)     (8,717,424)  
Prepaid expenses (136,160)     (530,926)  
Other receivables 23,097      (20,952)  
Other current assets 104,561      (173,090)  
Deposits and other assets (164,341)     273,792   
Accounts payable (39,371)     (193,362)  
Accrued expenses 1,140,253      501,699   
Due to students 375,640      1,197,343   
Deferred revenue 3,112,020      1,256,129   
Other current liabilities 125,440      (88,305)   
Net cash provided by (used in) operating activities 985,578      (5,748,633)  
       
Cash flows from investing activities:      
Purchase of finite life intangible assets (8,500)     —   
Purchases of courseware and accreditation (120,408)     (13,851)  
Purchases of property and equipment (8,848,395)     (3,276,510)  
Net cash used in investing activities (8,977,303)     (3,290,361)  
       
Cash flows from financing activities:      
Proceeds from warrants exercised 1,081,792      —   
Proceeds from stock options exercised 2,669,247      962,650   
Proceeds from sale of common stock net of underwriter costs —      16,044,879   
Disbursements for equity offering costs —      (51,282)  
Common stock short swing reclamation —      21,760   
Net cash provided by financing activities 3,751,039      16,978,007   

(Continued)

 

 
 

 

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

  Years Ended April 30,
  2021   2020
Net (decrease) increase in cash and cash equivalents $ (4,240,686)     $ 7,939,013   
Cash, cash equivalents and restricted cash at beginning of year 17,906,765      9,967,752   
Cash, cash equivalents and restricted cash at end of year $ 13,666,079      $ 17,906,765   
       
Supplemental disclosure cash flow information:      
Cash paid for interest $ 310,958      $ 1,208,285   
Cash paid for income taxes $ 57,208      $ 51,820   
       
Supplemental disclosure of non-cash investing and financing activities:      
Common stock issued for conversion of Convertible Notes $ 10,000,000      $ —   
Common stock issued for services $ —      $ 178,477   
Beneficial conversion feature on Convertible Debt $ —      $ 1,692,309   
Gain on extinguishment of debt $ —      $ 50,000   

 

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheet that sum to the same such amounts shown in the consolidated statement of cash flows:

 

  April 30,
  2021   2020
Cash and cash equivalents $ 8,513,290      $ 14,350,554   
Restricted cash 5,152,789      3,556,211   
Total cash and cash equivalents and restricted cash $ 13,666,079      $ 17,906,765   

 

 

 

 


The following information was filed by Aspen Group, Inc. (ASPU) on Tuesday, July 13, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Aspen Group, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aspen Group, Inc..

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account